AngioDynamics Stock

AngioDynamics EBIT

The EBIT of AngioDynamics (ANGO) as of Jun 22, 2026 is -24.33 T USD.In the previous year, EBIT was -34.28 T USD — a change of -29.01% (higher).

EBIT

-24.33 TUSD

YoY

-29.01%

Last updated:

In 2026, AngioDynamics's EBIT was -24.33 T USD, a -29.01% increase from the -34.28 T USD EBIT recorded in the previous year.

The AngioDynamics EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2006
10.3 base
Jan 1, 2007
-1.5 base
Jan 1, 2008
19.8 base
Jan 1, 2009
16.1 base
Jan 1, 2010
20.9 base
Jan 1, 2011
19.2 base
Jan 1, 2012
12 base
Jan 1, 2013
20.1 base
Jan 1, 2014
21.4 base
Jan 1, 2015
22.9 base
Jan 1, 2016
13.6 base
Jan 1, 2017
16.3 base
Jan 1, 2018
1.2 base
Jan 1, 2019
5.7 base
Jan 1, 2020
-2.5 base
YEAREBIT (M USD)
2030 est -
2029 est -
2028 est -
2027 est -30.98
2026 est -35.85
2025 -24.33
2024 -34.28
2023 -21
2022 -19.5
2021 -15.1
2020 -2.5
2019 5.7
2018 1.2
2017 16.3
2016 13.6
2015 22.9
2014 21.4
2013 20.1
2012 12
2011 19.2
2010 20.9
2009 16.1
2008 19.8
2007 -1.5
2006 10.3
Access this data via the Eulerpool API

AngioDynamics Revenue

AngioDynamics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
78.5 M USD
10.3 M USD
6.9 M USD
Jan 1, 2007
112.2 M USD
-1.5 M USD
-9.1 M USD
Jan 1, 2008
166.5 M USD
19.8 M USD
10.9 M USD
Jan 1, 2009
195.1 M USD
16.1 M USD
9.9 M USD
Jan 1, 2010
216 M USD
20.9 M USD
12.3 M USD
Jan 1, 2011
215.8 M USD
19.2 M USD
8.1 M USD
Jan 1, 2012
221.9 M USD
12 M USD
-5.2 M USD
Jan 1, 2013
341.9 M USD
20.1 M USD
-1.2 M USD
Jan 1, 2014
354.4 M USD
21.4 M USD
2.3 M USD
Jan 1, 2015
356.5 M USD
22.9 M USD
-3.4 M USD
Jan 1, 2016
353.9 M USD
13.6 M USD
-43.6 M USD
Jan 1, 2017
269.8 M USD
16.3 M USD
5 M USD
Jan 1, 2018
261.7 M USD
1.2 M USD
16.3 M USD
Jan 1, 2019
270.6 M USD
5.7 M USD
61.3 M USD
Jan 1, 2020
264.2 M USD
-2.5 M USD
-166.8 M USD

AngioDynamics Margins

AngioDynamics stock margins

The AngioDynamics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AngioDynamics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AngioDynamics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
57.96 %
13.12 %
8.79 %
Jan 1, 2007
59 %
-1.34 %
-8.11 %
Jan 1, 2008
61.62 %
11.89 %
6.55 %
Jan 1, 2009
61.56 %
8.25 %
5.07 %
Jan 1, 2010
58.8 %
9.68 %
5.69 %
Jan 1, 2011
58.25 %
8.9 %
3.75 %
Jan 1, 2012
56.47 %
5.41 %
-2.34 %
Jan 1, 2013
49.28 %
5.88 %
-0.35 %
Jan 1, 2014
50.85 %
6.04 %
0.65 %
Jan 1, 2015
49.31 %
6.42 %
-0.95 %
Jan 1, 2016
49.25 %
3.84 %
-12.32 %
Jan 1, 2017
53.37 %
6.04 %
1.85 %
Jan 1, 2018
54.99 %
0.46 %
6.23 %
Jan 1, 2019
57.65 %
2.11 %
22.65 %
Jan 1, 2020
56.89 %
-0.95 %
-63.13 %

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing AngioDynamics's EBIT

AngioDynamics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of AngioDynamics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

AngioDynamics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in AngioDynamics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about AngioDynamics stock

EBIT of AngioDynamics amounted to -34.28 T USD -24.33 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — AngioDynamics

All Key Metrics — AngioDynamics